• DAPI (hydrochloride): Precision DNA Quantitation in Complex

  2026-08-05

  Explore how DAPI (hydrochloride) enables high-precision DNA quantitation and cell cycle analysis in advanced tumor models. This article provides a deep dive into its mechanistic nuances and protocol optimization, distinguishing it from prior content by focusing on quantitative applications and assay decision-making.

• FXR-KLF11 Axis: CDCA Protects Against CI-AKI via JAK2/STAT3

  2026-08-05

  The reference study demonstrates that Chenodeoxycholic Acid (CDCA), acting as a potent FXR agonist, confers renal protection against contrast-induced acute kidney injury (CI-AKI) by transcriptionally upregulating KLF11 and suppressing the JAK2/STAT3 pathway. These insights define the FXR-KLF11 signaling axis as a promising molecular target for developing prophylactic strategies in acute kidney injury research.

• β-Elemene Suppresses Adipogenesis via AMPK Pathway Activatio

  2026-08-04

  This study demonstrates that β-Elemene inhibits adipogenesis in 3T3-L1 preadipocytes by activating the AMPK pathway, reversing insulin resistance, and reducing lipid accumulation. These findings provide mechanistic insights and support β-Elemene's use as a research tool for metabolic disease modeling.

• PD0325901 in Translational Control: Beyond MEK Inhibition

  2026-08-04

  Explore how PD0325901, a potent MEK inhibitor, enables advanced studies of translational control and apoptosis induction in cancer cells. This article offers a unique perspective on integrating pathway inhibition with emerging insights into mRNA translation surveillance.

• Membrane-Binding Domain of CARMIL: Mechanisms in Actin Regul

  2026-08-03

  This study uncovers the multifaceted role of CARMIL's membrane-binding (MB) domain in actin filament regulation, revealing how it targets, activates, and releases capping protein (CP) at membrane sites. The findings clarify longstanding questions about the spatial and temporal control of actin assembly, with implications for understanding cellular morphodynamics and migration.

• EZ Cap™ Cre mRNA (m1Ψ): Stable, Efficient Cre Recombinase mR

  2026-08-03

  EZ Cap™ Cre mRNA (m1Ψ) enables high-efficiency Cre recombinase expression with enhanced stability and reduced immunogenicity. This product supports advanced gene editing in extrahepatic tissues, offering reliable performance for research and therapy.

• Ziprasidone Hydrochloride (A5350): Reliable Solutions for Ad

  2026-08-02

  This article offers a scenario-driven, evidence-based guide for biomedical researchers seeking robust, reproducible results in cell viability and proliferation assays with Ziprasidone Hydrochloride (SKU A5350). Drawing on literature, validated product parameters, and real laboratory challenges, it demonstrates how this compound from APExBIO delivers both scientific and operational advantages.

• Tiamulin (Thiamutilin): Optimizing Veterinary and Lab Workfl

  2026-08-01

  Tiamulin (Thiamutilin) stands out for its dual antibacterial and anti-inflammatory actions, making it a cornerstone in veterinary and cell-based research. Learn how to harness its quantitative PK/PD benchmarks, troubleshoot ionophore interactions, and apply evidence-based protocols for reliable, reproducible results.

• 3-Deazaadenosine: Applied Workflows for Methylation & Antivi

  2026-07-31

  3-Deazaadenosine enables precision control over methylation and antiviral pathways, bridging epigenetics and infectious disease research. Explore practical protocols, troubleshooting guidance, and the latest translational insights—backed by APExBIO’s trusted quality.

• Biomimetic Chromatography for Pulmonary Drug Permeability Mo

  2026-07-31

  This study introduces a mass spectrometry-compatible biomimetic chromatography approach to model drug permeability across pulmonary membranes, comparing immobilised artificial membrane (IAM) chromatography and open tubular capillary electrochromatography (OT-CEC). The findings demonstrate that IAM-LC with MS provides robust, high-throughput predictions of lung absorption, supporting drug discovery and lead optimization workflows.

• Nanoparticle PTEN mRNA Delivery Reverses Trastuzumab Resista

  2026-07-30

  This study demonstrates that tumor microenvironment-responsive nanoparticles can systemically deliver PTEN mRNA to HER2-positive breast cancer, effectively reversing trastuzumab resistance by inhibiting the PI3K/Akt pathway. The findings provide a mechanistically targeted approach to overcoming antibody therapy resistance, with significant implications for future mRNA therapeutic design.

• Bacillus Strains and Media Govern γ-Glutamyl Peptide Product

  2026-07-30

  This study systematically demonstrates that both Bacillus strain selection and growth medium composition significantly affect the yield and diversity of γ-glutamyl peptides, including glutathione. The findings establish that medium composition has a more pronounced effect than strain identity, guiding researchers in optimizing glutathione metabolism research and peptide engineering workflows.

• Z-IETD-FMK (SKU B3232): Reliable Caspase-8 Inhibition in Res

  2026-07-29

  This article explores how Z-IETD-FMK (SKU B3232) addresses real-world challenges in apoptosis and immune cell assays. Drawing on current literature and rigorous protocols, we examine its application in T cell proliferation, NF-κB signaling, and TRAIL-mediated apoptosis inhibition. Researchers will find scenario-driven guidance and evidence-backed recommendations for integrating this caspase-8 inhibitor into diverse life science workflows.

• Rapid In Vivo Screening Uncovers BET and HDAC Targets in PDA

  2026-07-29

  This study integrates cell-based and in vivo screening to identify effective chemotherapeutic combinations for pancreatic ductal adenocarcinoma (PDA), highlighting the roles of BET bromodomain and HDAC inhibitors. The work establishes Rgs16::GFP as a robust readout for early lesion response and chemotherapeutic efficacy, with broad implications for translational cancer biology research.

• Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit:

  2026-07-28

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit addresses the challenge of resolving proteins and peptides between 1–10 kDa, where standard Tris-glycine SDS-PAGE systems show limited resolution. This product is suited for research workflows requiring high-resolution separation of small proteins and peptides, but it is not appropriate for clinical or diagnostic applications.

15195 records 1/1013 page Next 12345 下5页 Last page